HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SNDL
SNDL Inc.
SNDL lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SNDL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
SNDL's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SNDL PE Valuation
SNDL has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SNDL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Stable | |
| Limited | |
| High |
Analysts expect SNDL's losses to shrink, with revenue declining.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SNDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.18 | +$0.07 |
| Q2 2026 | -$0.07 | +$0.20 |
| Q1 2026 | -$0.04 | +$0.25 |
| Q4 2025 | -$0.05 | +$0.21 |
| Q3 2025 | -$0.25 | +$0.04 |
| Q2 2025 | -$0.27 | +$0.03 |
| Q1 2025 | -$0.29 | +$0.08 |
| Q4 2024 | -$0.26 | +$0.20 |
SNDL has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SNDL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
SNDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $165.7M | -3.5% |
| Q2 2026 | $165.8M | -3.7% |
| Q1 2026 | $137.7M | -4.4% |
| Q4 2025 | $177.5M | -2% |
| Q3 2025 | $171.7M | +3.1% |
| Q2 2025 | $172.1M | +7.3% |
| Q1 2025 | $144.1M | +3.6% |
| Q4 2024 | $181.2M | +3.7% |
SNDL's revenue grew through 2023 and has held roughly level since: $166M last quarter, down 3.5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -1.4% | +2.5 points |
| Q2 2026 | -2.3% | -3.5 points |
| Q1 2026 | -5.7% | -1.7 points |
| Q4 2025 | 4.1% | +34 points |
| Q3 2025 | -3.8% | +4 points |
| Q2 2025 | 1.2% | +3.3 points |
| Q1 2025 | -4% | -1.8 points |
| Q4 2024 | -30% | +4.7 points |
SNDL has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SNDL on cash flow, with more consistent year-over-year improvement.
SNDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $12.1M | -35% |
| Q2 2026 | $1.3M | -53% |
| Q1 2026 | $592.7K | -86% |
| Q4 2025 | $15M | +2.5% |
| Q3 2025 | $18.6M | +42% |
| Q2 2025 | $2.8M | +15% |
| Q1 2025 | $4.4M | +648% |
| Q4 2024 | $14.6M | +84% |
SNDL generated $29M in free cash flow over the past year, down 28% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SNDL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SNDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.8% | -9.7M shares |
| 1 year | -4% | -10.4M shares |
| 3 years | -5.2% | -13.5M shares |
| 5 years | +20% | +41.3M shares |
| Available history | +2217% | +236M shares |
SNDL has 247M diluted shares, down 4% from a year ago, with $30M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6.7M |
| Q2 2026 | $16.5M |
| Q1 2026 | $6.7M |
| Q4 2025 | $220,754 |
| Q3 2025 | $2,109 |
| Q2 2025 | — |
| Q1 2025 | $10.6M |
| Q4 2024 | $9.3M |
SNDL spent $30M buying back its own shares over the past year, up 52% from the year before.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SNDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -1.3x | Net Cash |
| Q4 2025 | -2.1x | Net Cash |
SNDL's net debt is less than a year of its operating earnings (EBITDA).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SNDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.8 | Neutral |
| Stochastic | 66.2 | Neutral |
SNDL's weekly RSI is 52 (neutral) and its Stochastic is 66 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SNDL PE vs Healthcare Sector
SNDL has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SNDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.31 | 6.1% above |
| 20 week MA | $1.31 | 6.1% above |
| 50 week MA | $1.45 | 4.1% below |
| 100 week MA | $1.60 | 13% below |
| 200 week MA | $1.69 | 18% below |
SNDL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
SNDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.7 | $4.73 | -79% |
| 2021 | $4.73 | $6.70 | +42% |
| 2022 | $6.70 | $2.08 | -69% |
| 2023 | $2.08 | $1.64 | -21% |
| 2024 | $1.64 | $1.79 | +9.1% |
| 2025 | $1.79 | $1.73 | -3.4% |
| 2026 YTD | $1.73 | $1.39 | -20% |
SNDL has the edge over HIMS on returns for 2026, with the stronger performance.